Stability of Refractive Outcomes After Hyperopic LASIK with and Without Mitomycin C
Author Information
Author(s): Saad Amr, Steinberg Johannes, Frings Andreas
Primary Institution: Department of Ophthalmology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University
Hypothesis
This study seeks to assess the efficacy, safety, and stability of refractive outcomes in hyperopic LASIK with and without the application of Mitomycin C.
Conclusion
Hyperopic LASIK with and without Mitomycin C showed comparable efficacy, safety, and stability of refractive outcomes at the six-month postoperative interval.
Supporting Evidence
- Both groups demonstrated highly effective and safe refractive outcomes.
- No intraoperative complications or postoperative adverse events were observed.
- Age and preoperative spherical equivalent did not significantly affect outcomes.
- Further investigation with longer follow-up periods and larger cohorts is necessary to confirm these results.
Takeaway
This study looked at two groups of people who had eye surgery to fix far-sightedness, one group got a special medicine and the other didn't, and both groups ended up seeing just as well after six months.
Methodology
This was a randomized, parallel group, controlled multicenter trial with 140 hyperopic eyes, comparing LASIK with and without Mitomycin C.
Potential Biases
The allocation sequence was generated and concealed by the trial statistician, minimizing potential randomization bias.
Limitations
The study had a relatively short follow-up period of up to 6 months and a small cohort.
Participant Demographics
The group was composed of 40% men and 60% women, with a mean age of 37 years (ranging from 20 to 54 years).
Statistical Information
P-Value
p=0.017
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website